We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Do NMDA Antagonists Prevent Neuronal Injury? Yes.

Gregory W. Albers, MD; Mark P. Goldberg, MD; Dennis W. Choi, MD, PhD
Arch Neurol. 1992;49(4):418-420. doi:10.1001/archneur.1992.00530280112031.
Text Size: A A A
Published online


Available evidence suggests that pharmacologic antagonism of the N-methyl-d-aspartate (NMDA) receptor can reduce neuronal death following hypoxic-ischemic insults. This evidence is derived from experimental models, as clinical trials have not yet been completed. The observed neuroprotective effects of NMDA antagonists do not represent isolated findings, but rather they are predictions of a strong hypothesis implicating excitotoxicity—the lethal overstimulation of neuronal glutamate receptors1,2—in the pathogenesis of hypoxicischemic central neuronal degeneration.

The excitotoxicity hypothesis has received independent support from microdialysis measurements,3,4 which indicate that during hypoxia-ischemia, extracellular glutamate levels can rise to neurotoxic concentrations.5,6 Other supporting observations include reduced hypoxic neuronal injury following excitatory pathway deafferentation, morphologic similarities between hypoxic injury and excitotoxic injury, and the prominence of neuronal calcium overload in the pathogenesis of both conditions.2,7,8 Although glutamate activates several receptor subtypes, the NMDA subtype may play a critical role in mediating the rapidly triggered


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.